-
Shop by category
- Accessories (23)
- Anti-Aging Products (434)
- Anti-Wrinkle Treatment Products (151)
- Biorevitalization (6)
- Botulinum Toxin (12)
- Chemical Peels (44)
- Dermal Fillers (76)
- Fat Dissolving / Lipolysis (10)
- Fillers For Body (5)
- Skin Boosters (34)
- Skin Moisturizers (115)
- Under Eye Creams (33)
- Excessive Facial Hair Inhibitors (5)
- Eye Care (27)
- Eyelash Growth Products (7)
- Hair Care, Treatment & Hair Growth Products (60)
- Men’s Health Products (25)
- Oral Care Products (22)
- Pet Health (2)
- Skin Care Products (286)
- Skin Lightening Products (212)
- Slider (0)
- Supplements & Drugs (376)
- Allergy (12)
- Anti-Addiction (5)
- Anti-Influenza (1)
- Antibiotics (47)
- Asthma (34)
- Brain & Antidepressants (34)
- Cancer Treatment (28)
- Diabetes (11)
- Heart / Blood Pressure (15)
- HIV, AIDS, Herpes & Hepatitis Treatment Medications (22)
- Homoeopathy (64)
- Immunosuppressants (11)
- Migraine (6)
- Thyroid Extract Supplements (7)
- Vitamins & Minerals (87)
- Wilson’s Disease (3)
- Topical Anesthetics / Pain Management (37)
- Weight Loss Treatment Products (22)
- Women's Health Products (63)
- Contraceptives / Birth Control Pills (22)
- Endocrine System (21)
- Sexual Wellness (13)
✓ We Dispatch The Freshest Batch
✓ Discreet Shipping Within 24h Daily
✓ Great Customer Service
✓ Competitive prices on all products
Boehringer Ingelheim
Showing the single result
-
Jardiance® Empagliflozin Tablets
Empagliflozin 5mg / 10mg / 12.5mg / 25mg + Metformin 500mg / 1000mg
Size: 30 Tablets
Brand name: Jardiance
From USD $178.00 Select options This product has multiple variants. The options may be chosen on the product page
Our focus globally is on helping patients and improving the quality of life for millions of people who rely on us. Boehringer Ingelheim is one the fastest-growing multinational pharmaceutical. It was set up in 2003 and currently ranks 8th among MNCs. Presently, Boehringer Ingelheim India operates through its business areas of Human Pharmaceuticals, Animal Health, and Clinical operations.
Boehringer Ingelheim India has entered into strategic alliances for diabetes management in India by partnering with Lupin Ltd and Torrent Pharma Ltd. for the sale and co-marketing of Boehringer Ingelheim’s Empagliflozin, Linagliptin and its combination products. These partnerships reaffirm our commitment to addressing challenges in diabetes management by enabling improved access to innovative medicine in India.
With the help of our commercial partnerships, Boehringer Ingelheim has transformed the lives of 2mn+ patients every year. Through its research and scientific excellence, Boehringer Ingelheim India will continue to introduce innovative products and bring together the healthcare ecosystem to address unmet medical needs.
